Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/17/2025

Safety of Using Strattera (Atomoxetine) and Remeron (Mirtazapine) Together

Mechanism of Action and Potential Interactions

  • Strattera (atomoxetine) is a selective norepinephrine reuptake inhibitor that primarily affects norepinephrine neurotransmission with minimal effect on serotonin 1
  • Remeron (mirtazapine) is classified as a noradrenergic and specific serotonergic antidepressant (NaSSA) that enhances both noradrenergic and serotonergic neurotransmission 2

Safety Profile

  • Mirtazapine is well-tolerated with its primary side effects being sedation (especially at lower doses) and potential weight gain 2

Common Pitfalls and Caveats

  • Avoid combining either medication with monoamine oxidase inhibitors (MAOIs) as this could lead to serious adverse effects 1

Special Populations

  • For adolescents with ADHD who may be prescribed atomoxetine, the addition of mirtazapine should be carefully considered, with attention to potential effects on driving ability 1
  • In patients with obesity or type 2 diabetes, be aware that mirtazapine may promote weight gain 3